AMRIXAL 30

Israel - English - Ministry of Health

Buy It Now

Active ingredient:
CYCLOBENZAPRINE HYDROCHLORIDE 30 MG
Available from:
PHARMASWISS ISRAEL LTD
ATC code:
M03BX08
Pharmaceutical form:
CAPSULES EXTENDED RELEASE
Administration route:
PER OS
Manufactured by:
APTALIS PHARMATECH INC, USA
Therapeutic group:
CYCLOBENZAPRINE
Therapeutic indications:
Amrixal is indicated as an adjunct to rest and physical therapy for relief of muscle spasm associated with acute, painful musculoskeletal conditions. Improvement is manifested by relief of muscle spasm and its associated signs and symptoms, namely, pain, tenderness, and limitation of motion.
Authorization number:
146593320300
Authorization date:
2011-08-01

Similar products

Search alerts related to this product

Share this information